Sector: Pharmaceuticals & Biotechnology

Large Cap

Neuland Laboratories Share Price

NEULANDLAB

₹22,901

-400.00(-1.72%)

24th Aug 2026 | 3:28 PM

NSE : NEULANDLAB

Open Free Demat Account

Neuland Laboratories Performance

Price Movement

₹22901.00

₹22834.00

₹23399.00

↘ Today's Low↗ Today's High

1 Year Performance

₹22901.00

₹11500.00

₹23881.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹23,399.00

Low₹22,834.00

Open at₹23,399.00

Prev Close₹23,301.00

Volumes31.93 K

Avg Price₹23,038.59

Lower Circuit₹18,641.00

Upper Circuit₹27,961.00

Historical Performance

3M High₹23,881.00

3M Low₹16,401.00

1 Yr High₹23,881.00

1 Yr Low₹11,500.00

3 Yr High₹23,881.00

3 Yr Low₹3,400.00

5 Yr High₹23,881.00

5 Yr Low₹967.00

Summary

As of 25-08-2026 00:01, Neuland Laboratories Ltd. share price today is ₹0, with a change of ₹-23301.00 (-100.00%) from the previous close of ₹23301. The stock opened at ₹23399 and traded between ₹22834 and ₹23399, with a total traded volume of 31931 shares. The company has a market capitalization of ₹29894.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹23881 and ₹11500, respectively.

Neuland Laboratories Ltd. valuation metrics include a P/E ratio of 60.1, EPS of ₹283.71, and book value of ₹14.80. Profitability indicators show ROE of 19.42% along with a dividend yield of 0.1%. Neuland Laboratories Ltd. has reported revenue of ₹2371.81 Cr and net profit of ₹497.77 Cr.

Neuland Laboratories Ltd. technical indicators include Day RSI at 67.91, Day MFI at 88.15, Day ADX at 49.56. Additional indicators include Commodity Channel Index (CCI) at 71 and Williams %R at -12.27. Momentum indicators show Day MACD at 1253.5, Day MACD Signal Line at 1150.16, DayATR at 754.85. Rate of Change indicators for Neuland Laboratories Ltd. include ROC125 at 70.47 and ROC21 at 26.42.

Exponential moving averages include EMA5 at ₹23319.4, EMA10 at ₹22884.8, EMA12 at ₹22672.8, EMA20 at ₹21896, EMA26 at ₹21419.3, EMA50 at ₹20038.2, EMA100 at ₹18344.8, EMA200 at ₹16731.1. Simple moving averages include SMA5 at ₹23438, SMA10 at ₹23139.8, SMA20 at ₹21525.4, SMA30 at ₹20603.7, SMA50 at ₹19624.1, SMA100 at ₹17659.8, SMA150 at ₹16118.4, SMA200 at ₹16157.1.

Support levels for Neuland Laboratories are placed at First Support ₹23097.67, Second Support ₹22894.33, Third Support ₹22608.67. Resistance levels are seen at First Resistance ₹23586.67, Second Resistance ₹23872.33, Third Resistance ₹24075.67. Neuland Laboratories Ltd. shareholding pattern shows promoter holding at 32.62%, FII holding at 21.08%, DII holding at 0%, public holding at 29.79%.

Neuland Laboratories Fundamentals

Market Cap

High in industry

29,894.90 Cr.

PE Ratio (TTM)

High in industry

60.10

Dividend Yield

Low in industry

0.10

Net Profit TTM

182.6% incr over last year

497.77

Net Profit Growth

182.6% incr over last year

497.77

PEG Ratio

Above industry Median

0.30

ROE

13.8% incr over last year

19.42

Operating Revenue TTM

2,371.81

Operating Revenue Growth

78.3% incr over last year

Book Value

High in industry

14.80

MFI

MFI strongly Overbought

88.15

RSI

RSI is mid-range

67.91

EPS (TTM)

283.71

Debt to Equity

0.10

Face Value

Operating Profit Margin Qtr.

27.98

Operating Profit Qtr.

222.89

Net Profit Qtr.

147.67

Operating Revenue Qtr.

641.58

PB Ratio

14.80

Neuland Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	641.58	776.25	439.71	514.27	292.75
Operating Expense	419	469.35	362.78	359.15	258.46
Operating Profit	222.58	306.90	76.93	155.12	34.29
Depreciation	26.56	25.09	23.92	22.54	20.19
Interest	6.97	7.23	6.79	5.34	4.58
Tax	50.17	74.52	13.86	32.58	3.67
Net Profit	147.36	212.52	40.42	96.46	13.71

Neuland Laboratories Technicals

Neuland Laboratories Ltd. EMA & SMA

₹22901.00

-667.00 (-2.83%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹23319.4

Day EMA10 ₹22884.8

Day EMA12 ₹22672.8

Day EMA20 ₹21896

Day EMA26 ₹21419.3

Day EMA50 ₹20038.2

Day EMA100 ₹18344.8

Day EMA200 ₹16731.1

Neuland Laboratories Support and Resistance

Resistance

First Resistance₹23586.67

Second Resistance₹23872.33

Third Resistance₹24075.67

Support

First Support₹23097.67

Second Support₹22894.33

Third Support₹22608.67

Technical Indicators

Day RSI67.91

Day MFI88.15

Day ADX49.56

Day Commodity Channel Index71.00

William-12.27

Day MACD1253.50

Day MACD Signal Line1150.16

Day ATR754.85

Day ROC12570.47

Day ROC2126.42

Neuland Laboratories Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	32.7	32.7	32.6	32.6	32.6	32.6
FII	22.1	21.7	20.6	20.9	20.5	21.1
DII	11.4	12	14	14.7	15.8	16.5
Public	33.8	33.7	32.8	31.8	31.1	29.8

Neuland Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	14.5 K	30.12 K	48.15%
Week	24.73 K	54.18 K	45.64%
1 Month	36.46 K	1.11 L	32.85%
6 Month	24.24 K	66.52 K	36.44%

Neuland Laboratories SWOT Analysis

Strengths26

Weakness10

Opportunity6

Threats1

Benjamin Graham Value Screen

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter

Stringent DVM Screener

Weekly Screener: High Momentum Score Stocks (subscription)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Near 52 Week High

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Neuland Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
24 Jul, 2026	34	FINAL	24 Jul, 2026	Equity Share
18 Jul, 2025	12	FINAL	18 Jul, 2025	Equity Share
12 Jul, 2024	14	FINAL		Equity Share
11 Jul, 2023	10	FINAL		Equity Share
14 Jul, 2022	5	FINAL	15 Jul, 2022	Equity Share
29 Jun, 2021	3	FINAL		Equity Share
10 Nov, 2020	2	INTERIM	11 Nov, 2020	Equity Share
18 Feb, 2020	2	INTERIM	20 Feb, 2020	Equity Share
27 Jun, 2019	1.2	FINAL		Equity Share
04 Aug, 2016	2	FINAL		Equity Share

Neuland Laboratories Stock Comparison

Financials	Rubicon Research Ltd.	Anthem Biosciences Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,766	₹883.60	₹1,436.80	₹1,862	₹2,374.50	₹212.43
% Change	2.39%	1.39%	-1.41%	-0.05%	-0.40%	-0.58%
Revenue TTM (₹ Cr)	₹1,935.80	₹2,002.34	₹2,250.36	₹9,683.45	₹14,737.88	₹9,205.28
Net Profit TTM (₹ Cr)	₹288.22	₹575.94	₹361.74	₹1,011.39	₹2,042.67	₹-313.62
PE TTM	99.10	85.20	85.50	34.90	48.20	-90.70
1 Year Return	255.61	5.9	57.4	24.77	-8.55	10.85
ROCE	24.32	27.56	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3171.00

+0.06%

GLAND

Gland Pharma Ltd.

₹ 2811.90

-0.26%

LAURUSLABS

Laurus Labs Ltd.

₹ 1801.00

-0.06%

ALKEM

Alkem Laboratories Ltd.

₹ 5350.00

-0.93%

BIOCON

Biocon Ltd.

₹ 409.40

-1.48%

DIVISLAB

Divi's Laboratories Ltd.

₹ 8496.00

-1.17%

GRANULES

Granules India Ltd.

₹ 857.00

-0.13%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3581.00

-1.62%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1103.80

-1.45%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2390.70

+3.14%

WOCKPHARMA

Wockhardt Ltd.

₹ 1902.00

+0.83%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1608.00

-0.82%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1910.00

+0.40%

IPCALAB

Ipca Laboratories Ltd.

₹ 1921.00

+0.51%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2930.00

+0.96%

PFIZER

Pfizer Ltd.

₹ 4886.00

-1.85%

ABBOTINDIA

Abbott India Ltd.

₹ 26450.00

+0.84%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4886.50

-0.20%

LUPIN

Lupin Ltd.

₹ 2188.00

-0.63%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1190.00

+1.30%

CIPLA

Cipla Ltd.

₹ 1437.90

+0.40%

FAQ's on NEULANDLAB

What is the current share price of Neuland Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Neuland Laboratories Ltd. is ₹ 22901 on the NSE and ₹ 22946 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Neuland Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Neuland Laboratories Ltd. is approximately ₹ 29894.9 Cr.

What are the PE and PB ratios for Neuland Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Neuland Laboratories Ltd. is 60.1, and the Price-to-Book (PB) ratio is 14.8.

What is the 52-Week High and Low for Neuland Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Neuland Laboratories Ltd. shares was ₹ 23881, and the lowest price was ₹ 11500.

What is the current dividend yield for Neuland Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Neuland Laboratories Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Neuland Laboratories Ltd.?

Significant shareholdings in Neuland Laboratories Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Neuland Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Neuland Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Neuland Laboratories Ltd.?

Neuland Laboratories Ltd. last declared a FINAL dividend of ₹ 34 per share for the financial period ending 2026. The record date was set as 2026-07-24, and the payment was/is scheduled around 2026-07-24. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy